A High-throughput Neutralization Test for SARS-CoV-2 Based on a Pseudovirus Containing Monomeric Infrared Fluorescent Protein as Reporter
This test can be performed in a biosafety level 2 laboratory
Published: 7th June 2021

IP Status
- Provisional patent
Seeking
- Development partner
- Commercial partner
- Licensing
- Seeking investment